Delaware
|
0-3936
|
11-1826363
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
80 Cabot Court
|
|
|
Hauppauge, New York
|
|
11788
|
(Address of principal executive offices)
|
|
(Zip Code)
|
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230-425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c)) |
Item 2.02. | Results of Operations and Financial Condition. |
Item 9.01. | Financial Statements and Exhibits. |
(d) | Exhibits: |
99.1 | Press release dated March 6, 2014. |
|
|
Orbit International Corp.
|
|
|
|
|
|
|
By:
|
/s/ Mitchell Binder
|
|
|
|
Mitchell Binder
|
|
|
|
Chief Executive Officer and President
|
|
· | Net sales were $5,807,000, as compared to $7,903,000. |
· | Gross margin was 34.3%, as compared to 42.8%. |
· | Net loss was $2,726,000 ($0.62 loss per share), as compared to net income of $278,000 ($0.06 per diluted share). |
o | Net loss for the 2013 fourth quarter included a non-cash charge of $2,252,000 of deferred tax expense related to a full valuation allowance taken on our net deferred tax asset and $161,000 in accelerated non-cash depreciation and amortization expense related to the closing of our TDL Quakertown operation. Excluding these charges, net loss for the 2013 fourth quarter was $313,000 ($0.07 loss per share). |
o | Net income for the 2012 fourth quarter included a non-cash goodwill impairment charge of $820,000 representing the write-off of the remaining goodwill associated with our Tulip Development Laboratory, Inc. (“TDL”) subsidiary. Excluding this charge, net income for 2012 fourth quarter was $1,098,000 ($0.24 per diluted share). |
· | Earnings before interest, taxes, depreciation and amortization, goodwill impairment and stock based compensation (EBITDA, as adjusted) was a loss of $178,000 ($0.04 loss per share), as compared to earnings of $1,207,000 ($0.27 per diluted share). |
· | Net sales were $24,838,000, as compared to $29,438,000. |
· | Gross margin was 37.6%, as compared to 39.6%. |
· | Net loss was $2,570,000 ($0.58 loss per share), as compared to a net loss of $135,000 ($0.03 loss per share). |
o | Excluding the aforementioned 2013 fourth quarter charges, for the full year 2013, net loss was $157,000 ($0.04 loss per share). |
o | In addition to the aforementioned 2012 fourth quarter charge of $820,000, the net loss for the full 2012 year also included a non-recurring charge of $1,194,000 in connection with employment contract provisions of a departing senior officer, which was recorded in the 2012 first quarter. Excluding both charges, net income for the full year 2012 was $1,879,000 ($0.41 per diluted share). |
· | EBITDA, as adjusted, was $370,000 ($0.08 per diluted share), as compared to $1,378,000 ($0.30 per diluted share). |
· | Backlog at December 31, 2013 was $10.1 million as compared to $12.7 million at September 30, 2013 and $15.9 million at December 31, 2012. |
CONTACT
|
or
|
Investor Relations Counsel
|
|
Mitchell Binder
|
Lena Cati
|
||
President & Chief Executive Officer
|
212-836-9611
|
||
631-435-8300
|
|
The Equity Group Inc.
|
|
Three Months Ended
December 31,
(unaudited)
|
Year Ended
December 31,
(unaudited) (audited)
|
||||||||||||||
|
2013
|
2012
|
2013
|
2012
|
||||||||||||
|
||||||||||||||||
Net sales
|
$
|
5,807
|
$
|
7,903
|
$
|
24,838
|
$
|
29,438
|
||||||||
|
||||||||||||||||
Cost of sales
|
3,818
|
4,522
|
15,495
|
17,777
|
||||||||||||
|
||||||||||||||||
Gross profit
|
1,989
|
3,381
|
9,343
|
11,661
|
||||||||||||
|
||||||||||||||||
Selling, general and administrative expenses
|
2,421
|
2,305
|
9,540
|
9,732
|
||||||||||||
|
||||||||||||||||
Costs related to non-renewal
of chief operating officer contract
|
-
|
-
|
-
|
1,194
|
||||||||||||
|
||||||||||||||||
Restructuring costs
|
29
|
-
|
29
|
-
|
||||||||||||
|
||||||||||||||||
Goodwill impairment
|
-
|
820
|
-
|
820
|
||||||||||||
|
||||||||||||||||
Interest expense
|
13
|
23
|
59
|
124
|
||||||||||||
|
||||||||||||||||
Investment and other (income)
|
(11
|
)
|
(42
|
)
|
(22
|
)
|
(144
|
)
|
||||||||
|
||||||||||||||||
(Loss) income before taxes
|
(463
|
)
|
275
|
(263
|
)
|
(65
|
)
|
|||||||||
|
||||||||||||||||
Income tax provision (benefit)
|
2,263
|
(3
|
)
|
2,307
|
70
|
|||||||||||
|
||||||||||||||||
Net (loss) income
|
$
|
(2,726
|
)
|
$
|
278
|
$
|
(2,570
|
)
|
$
|
(135
|
)
|
|||||
|
||||||||||||||||
|
||||||||||||||||
Basic (loss) earnings per share
|
$
|
(0.62
|
)
|
$
|
0.06
|
$
|
(0.58
|
)
|
$
|
(0.03
|
)
|
|||||
|
||||||||||||||||
Diluted (loss) earnings per share
|
$
|
(0.62
|
)
|
$
|
0.06
|
$
|
(0.58
|
)
|
$
|
(0.03
|
)
|
|||||
|
||||||||||||||||
Weighted average number of shares outstanding:
|
||||||||||||||||
Basic
|
4,416
|
4,510
|
4,453
|
4,591
|
||||||||||||
Diluted
|
4,416
|
4,528
|
4,453
|
4,591
|
|
Three Months Ended
December 31,
|
Year Ended
December 31,
|
||||||||||||||
|
2013
|
2012
|
2013
|
2012
|
||||||||||||
EBITDA (as adjusted) Reconciliation
|
||||||||||||||||
Net (loss) income
|
$
|
(2,726
|
)
|
$
|
278
|
$
|
(2,570
|
)
|
$
|
(135
|
)
|
|||||
Interest expense
|
13
|
23
|
59
|
124
|
||||||||||||
Tax expense (benefit)
|
2,263
|
(3
|
)
|
2,307
|
70
|
|||||||||||
Depreciation and amortization
|
245
|
74
|
463
|
288
|
||||||||||||
Goodwill impairment
|
-
|
820
|
-
|
820
|
||||||||||||
Stock based compensation
|
27
|
15
|
111
|
211
|
||||||||||||
EBITDA (as adjusted) (1)
|
$
|
(178
|
)
|
$
|
1,207
|
$
|
370
|
$
|
1,378
|
|||||||
|
||||||||||||||||
EBITDA (as adjusted) Per Diluted Share Reconciliation
|
||||||||||||||||
Net (loss) income
|
$
|
(0.62
|
)
|
$
|
0.06
|
$
|
(0.58
|
)
|
$
|
(0.03
|
)
|
|||||
Interest expense
|
0.00
|
0.01
|
0.01
|
0.03
|
||||||||||||
Tax expense (benefit)
|
0.51
|
0.00
|
0.52
|
0.01
|
||||||||||||
Depreciation and amortization
|
0.06
|
0.02
|
0.10
|
0.06
|
||||||||||||
Goodwill impairment
|
0.00
|
0.18
|
0.00
|
0.18
|
||||||||||||
Stock based compensation
|
0.01
|
0.00
|
0.03
|
0.05
|
||||||||||||
EBITDA (as adjusted) per diluted share (1)
|
$
|
(0.04
|
)
|
$
|
0.27
|
$
|
0.08
|
$
|
0.30
|
(1) | The EBITDA (as adjusted) tables presented are not determined in accordance with accounting principles generally accepted in the United States of America. Management uses adjusted EBITDA (as adjusted) to evaluate the operating performance of its business. It is also used, at times, by some investors, securities analysts and others to evaluate companies and make informed business decisions. EBITDA (as adjusted) is also a useful indicator of the income generated to service debt. EBITDA (as adjusted) is not a complete measure of an entity's profitability because it does not include costs and expenses for interest, depreciation and amortization, goodwill impairment, income taxes and stock based compensation. EBITDA (as adjusted) as presented herein may not be comparable to similarly named measures reported by other companies. |
|
Year Ended December 31,
|
|||||||
Reconciliation of EBITDA, as adjusted, to
cash flows provided by (used in) operating activities (1)
|
2013
|
2012
|
||||||
EBITDA (as adjusted)
|
$
|
370
|
$
|
1,378
|
||||
Interest expense
|
(59
|
)
|
(124
|
)
|
||||
Tax expense
|
(55
|
)
|
(70
|
)
|
||||
Bond amortization
|
10
|
2
|
||||||
Gain on sale of marketable securities
|
(7
|
)
|
(5
|
)
|
||||
Net change in operating assets and liabilities
|
3,726
|
(2,135
|
)
|
|||||
Cash flows provided by (used in) operating activities
|
$
|
3,985
|
$
|
(954
|
)
|
|
December 31, 2013
(unaudited)
|
December 31, 2012
(audited)
|
||||||
ASSETS
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
2,562,000
|
$
|
610,000
|
||||
Investments in marketable securities
|
243,000
|
251,000
|
||||||
Accounts receivable, less allowance for doubtful accounts
|
2,981,000
|
5,372,000
|
||||||
Inventories
|
11,803,000
|
13,271,000
|
||||||
Costs and estimated earnings in excess of billings on uncompleted contracts
|
-
|
875,000
|
||||||
Deferred tax asset
|
-
|
447,000
|
||||||
Other current assets
|
264,000
|
252,000
|
||||||
|
||||||||
Total current assets
|
17,853,000
|
21,078,000
|
||||||
|
||||||||
Property and equipment, net
|
975,000
|
1,099,000
|
||||||
Goodwill
|
868,000
|
868,000
|
||||||
Deferred tax asset
|
-
|
1,806,000
|
||||||
Other assets
|
35,000
|
125,000
|
||||||
|
||||||||
Total assets
|
$
|
19,731,000
|
$
|
24,976,000
|
||||
|
||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
Current liabilities:
|
||||||||
Current portion of long term obligations
|
$
|
-
|
$
|
33,000
|
||||
Notes payable-bank
|
2,100,000
|
3,324,000
|
||||||
Accounts payable
|
510,000
|
741,000
|
||||||
Liability associated with non-renewal of senior officer contract
|
36,000
|
661,000
|
||||||
Income taxes payable
|
25,000
|
2,000
|
||||||
Accrued expenses
|
1,149,000
|
1,294,000
|
||||||
Customer advances
|
17,000
|
88,000
|
||||||
|
||||||||
Total current liabilities
|
3,837,000
|
6,143,000
|
||||||
|
||||||||
Liability associated with non-renewal of senior officer contract, net of current portion
|
4,000
|
41,000
|
||||||
Long term debt, net of current portion
|
-
|
8,000
|
||||||
|
||||||||
Total liabilities
|
3,841,000
|
6,192,000
|
||||||
|
||||||||
Stockholders’ Equity
|
||||||||
Common stock
|
523,000
|
510,000
|
||||||
Additional paid-in capital
|
22,824,000
|
22,726,000
|
||||||
Treasury stock
|
(2,133,000
|
)
|
(1,700,000
|
)
|
||||
Accumulated other comprehensive loss
|
(5,000
|
)
|
(3,000
|
)
|
||||
Accumulated deficit
|
(5,319,000
|
)
|
(2,749,000
|
)
|
||||
|
||||||||
Stockholders’ equity
|
15,890,000
|
18,784,000
|
||||||
|
||||||||
Total liabilities and stockholders’ equity
|
$
|
19,731,000
|
$
|
24,976,000
|